Yamada et al[27] noted that CK7 expression was a useful biomarker for predicting the outcome of stage I/IIA/IIB ESCC patients, and there were 28 positive staining cases (28/126, 22%). This evidence concerns the gene KRT7 and esophageal squamous cell carcinoma.